• 1

    Laco J: “Nail Disorders,” in Principles and Practice of Podiatric Medicine, ed by V Hetherington, p 520, Churchill Livingstone, New York, 1990..

    • PubMed
    • Export Citation
  • 2

    Foley G, Allen J: Wound healing after toenail avulsion. .Foot 4::88. ,1994. .

  • 3

    Rinaldi R, Sabia M, Gross J: The treatment and prevention of infection in phenol alcohol matricectomies. .JAPA 72::453. ,1982. .

  • 4

    Zuber T, Pfenninger J: Management of ingrown toenails. .Am Fam Physician 52::181. ,1995. .

  • 5

    Goslin R: A comparison of the dilution and no dilution of phenol with alcohol following nail avulsions. .Foot 2::225. ,1992. .

  • 6

    Beaton D: Ingrown toenails: a patient evaluation of phenolisation versus wedge excision. .Chiropodist 45::62. ,1990. .

  • 7

    Altman M, Sulesky C, Delisle R, et al: Silver sulfadiaxine and hydrocortisone cream 1% in the management of phenol matricectomy. .JAPMA 80::545. ,1990. .

  • 8

    Dagnell J: An evaluation of povidone iodine prophylaxis following nail matrix phenolisation. .Chiropodist 5::235. ,1986. .

  • 9

    Brennan S, Leaper D: The effect of antiseptics on the healing wound: a study using the rabbit ear chamber. .Br J Surg 72::780. ,1985. .

  • 10

    Burks R: Povidone-iodine solution in wound treatment. .Phys Ther 78::212. ,1998. .

  • 11

    Kjolseth D, Frank J, Barker J, et al: Comparison of the effects of commonly used wound agents on epithelialization and neovascularization. .J Am Coll Surg 179::305. ,1994. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Mayer D, Tsapogas M: Povidone-iodine and wound healing: a critical review. .Wounds 5::14. ,1993. .

  • 13

    Findlay D: Modern wound dressings: what to use. .Aust Fam Physician 23::824. ,1994. .

  • 14

    Dove A, Sloan J, Moulder T, et al: Dressings of the nailbed following nail avulsion. .J Hand Surg [Br] 13::408. ,1988. .

  • 15

    Machin D, Campbell MJ, Fayers PM, et al: Sample Size Tables for Clinical Studies, Blackwell Science, Oxford, England, 1997..

    • PubMed
    • Export Citation
  • 16

    Portney LG, Watkins MP: Foundations of Clinical Research: Applications to Practice, p 350, Appleton & Lange, Stamford, CT, 1993..

    • PubMed
    • Export Citation
  • 17

    Bailar JC III, Mosteller F (eds): Medical Uses of Statistics, 2nd Ed, p 102, NEJM Books, Boston, MA, 1992..

    • PubMed
    • Export Citation
  • 18

    Spilker B: Guide to Clinical Trials, Lippincott-Raven, Philadelphia, 1996..

    • PubMed
    • Export Citation

Wound Healing and Infection in Nail Matrix Phenolization Wounds

Does Topical Medication Make a Difference?

Russell Dovison Director, Bayside Podiatry Pty Ltd, Bonbeach, Victoria, Australia.

Search for other papers by Russell Dovison in
Current site
Google Scholar
Anne-Maree Keenan Fellow, Australian Faculty of Public Health Medicine; Senior Lecturer, School of Exercise and Health Sciences, University of Western Sydney, Locked Bag 1797, Penrith DC, New South Wales 1797, Australia.

Search for other papers by Anne-Maree Keenan in
Current site
Google Scholar
 BAppSc(Pod), MAppSc

After nail matrix ablation using phenolization, a medicated wound dressing (10% povidone iodine), an amorphous hydrogel dressing (Intrasite Gel), and a control dressing (paraffin gauze) were evaluated. Forty-two participants, randomly divided into three dressing groups, were evaluated. Healing time did not differ between the 10% povidone iodine (33 days), amorphous hydrogel (33 days), and the control dressing (34 days). For all groups, the clinical infection rate was lower than in previous studies, and there was no clinical difference between groups (one infection in the povidone iodine and control groups; none in the amorphous hydrogel group). However, in the amorphous hydrogel group, other complications, such as hypergranulation, were more likely. This investigation indicated that medicated or hydrogel dressings did not enhance the rate of healing or decrease infection rates. (J Am Podiatr Med Assoc 91(5): 230-233, 2001)